 | • レポートコード：MRC2202A019 • 出版社/出版日：Persistence Market Research / 2021年12月13日 • レポート形態：英文、PDF、216ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界のボツリヌス毒素市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、製品別（タイプA、タイプB）分析、用途別（化粧品、治療薬）分析、エンドユーザー別（病院、専門クリニック、スパ＆ビューティークリニック）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成でまとめております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・世界のボツリヌス毒素市場規模：製品別（タイプA、タイプB） ・世界のボツリヌス毒素市場規模：用途別（化粧品、治療薬） ・世界のボツリヌス毒素市場規模：エンドユーザー別（病院、専門クリニック、スパ＆ビューティークリニック） ・世界のボツリヌス毒素市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Botulinum Toxin Market – Scope of Report
The latest publication by Persistence Market Research on the global botulinum toxin market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for botulinum toxin products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the botulinum toxin market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the botulinum toxin market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the botulinum toxin market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the botulinum toxin market offers information divided into four important segments – product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Type A
Type B
Application
Cosmetics
Crow’s Feet
Forehead Lines
Frown Lines/Glabellar
Square Jaw/Masseter
Others
Therapeutic
Chronic Migraine
Muscle Spasm
Over Reactive Bladder
Hyperhidrosis
Others
End User
Hospitals
Specialty Clinics
Spa & Beauty Clinics
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for botulinum toxin over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the botulinum toxin market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the botulinum toxin market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the botulinum toxin market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends
4. Key Success Factors
4.1. Global Treatment Adoption Pattern
4.2. Key Regulations
4.3. Reimbursement Scenario
4.4. Product Approvals
4.5. Key Promotional Strategies of Manufacturers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Rising Incidence of migraine.
5.2.2. Widespread adoption of Botulinum Toxin across regions.
5.2.3. Growing popularity of Minimally Invasive Surgery.
5.2.4. Increased disposable income.
5.2.5. Increased healthcare expenditure.
5.2.6. Product adoption in emerging countries.
5.2.7. Increased demand for cosmetic procedures
5.2.8. Growing awareness about beauty and appearances.
5.2.9. Average cost of Botulinum Toxin/Unit
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Application
6.4.3. Revenue By End-User
6.4.4. Revenue By Country
6.5. 2020 Market Scenario
7. Global Botulinum Toxin Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021–2031
8.3.1. Type A
8.3.2. Type B
8.4. Market Attractiveness Analysis By Product
9. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Application, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021–2031
9.3.1. Cosmetics
9.3.1.1. Crow’s Feet
9.3.1.2. Forehead Lines
9.3.1.3. Frown Lines/Glabellar
9.3.1.4. Square Jaw/Masseter
9.3.1.5. Others
9.3.2. Therapeutic
9.3.2.1. Chronic Migraine
9.3.2.2. Muscle Spasm
9.3.2.3. Over reactive Bladder
9.3.2.4. Hyperhidrosis
9.3.2.5. Others
9.4. Market Attractiveness Analysis By Application
10. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By End-User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By End-User, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2021–2031
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Spa & Beauty Clinic
10.4. Market Attractiveness Analysis By End-User
11. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 – 2020
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By End-User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
13.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By End-User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By End-User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
15.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By End-User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
16.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By End-User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2016-2020
17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By End-User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By End-User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Country Level Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Country
19.1.2. Global VS. Country Growth Comparison
19.1.3. Pricing Analysis, By Country
19.2. U.S. Botulinum Toxin Market Analysis
19.2.1. By Product
19.2.2. By Application
19.2.3. By End-User
19.3. Canada Botulinum Toxin Market Analysis
19.3.1. By Product
19.3.2. By Application
19.3.3. By End-User
19.4. Brazil Botulinum Toxin Market Analysis
19.4.1. By Product
19.4.2. By Application
19.4.3. By End-User
19.5. Mexico Botulinum Toxin Market Analysis
19.5.1. By Product
19.5.2. By Application
19.5.3. By End-User
19.6. Argentina Botulinum Toxin Market Analysis
19.6.1. By Product
19.6.2. By Application
19.6.3. By End-User
19.7. U.K. Botulinum Toxin Market Analysis
19.7.1. By Product
19.7.2. By Application
19.7.3. By End-User
19.8. Germany Botulinum Toxin Market Analysis
19.8.1. By Product
19.8.2. By Application
19.8.3. By End-User
19.9. France Botulinum Toxin Market Analysis
19.9.1. By Product
19.9.2. By Application
19.9.3. By End-User
19.10. Italy Botulinum Toxin Market Analysis
19.10.1. By Product
19.10.2. By Application
19.10.3. By End-User
19.11. Spain Botulinum Toxin Market Analysis
19.11.1. By Product
19.11.2. By Application
19.11.3. By End-User
19.12. BENELUX Botulinum Toxin Market Analysis
19.12.1. By Product
19.12.2. By Application
19.12.3. By End-User
19.13. Russia Botulinum Toxin Market Analysis
19.13.1. By Product
19.13.2. By Application
19.13.3. By End-User
19.14. Japan Botulinum Toxin Market Analysis
19.14.1. By Product
19.14.2. By Application
19.14.3. By End-User
19.15. China Botulinum Toxin Market Analysis
19.15.1. By Product
19.15.2. By Application
19.15.3. By End-User
19.16. South Korea Botulinum Toxin Market Analysis
19.16.1. By Product
19.16.2. By Application
19.16.3. By End-User
19.17. India Botulinum Toxin Market Analysis
19.17.1. By Product
19.17.2. By Application
19.17.3. By End-User
19.18. ASEAN Botulinum Toxin Market Analysis
19.18.1. By Product
19.18.2. By Application
19.18.3. By End-User
19.19. Australia Botulinum Toxin Market Analysis
19.19.1. By Product
19.19.2. By Application
19.19.3. By End-User
19.20. New Zealand Botulinum Toxin Market Analysis
19.20.1. By Product
19.20.2. By Application
19.20.3. By End-User
19.21. GCC Countries Botulinum Toxin Market Analysis
19.21.1. By Product
19.21.2. By Application
19.21.3. By End-User
19.22. Turkey Botulinum Toxin Market Analysis
19.22.1. By Product
19.22.2. By Application
19.22.3. By End-User
19.23. South Africa Botulinum Toxin Market Analysis
19.23.1. By Product
19.23.2. By Application
19.23.3. By End-User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1.1. Regional footprint of Players
20.4.1.2. Method foot print by Players
20.4.1.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Allergan PLC
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Application/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. U.S. WorldMeds
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Application/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Hugh Source (International) Ltd.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Application/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Galderma laboratories.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Application/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Revance Therapeutics, Inc.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Application/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Ipsen Pharma
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Application/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Merz Pharma GmbH & Co. KGaA
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Application/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Daewoong Pharmaceuticals Co.,Ltd.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Application/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. HUGEL Pharma
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Application/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Medy-Tox Inc
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Application/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. Lanzhou Institute of Biological Products Co., Ltd
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Application/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Teijin Pharma Ltd
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Profitability by Market Segments (Product/Application/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Product Strategy
21.3.12.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Botulinum Toxin Market Value (US$ Mn) by Region, 2016–2031Table 02: Global Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 03: Global Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 04: Global Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 05: North America Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 06: North America Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 07: North America Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 08: North America Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 09: Latin America Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 10: Latin America Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 11: Latin America Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 12: Latin America Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 13: Europe Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 14: Europe Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 15: Europe Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 16: Europe Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 17: East Asia Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 18: East Asia Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 19: East Asia Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 20: East Asia Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 21: South Asia Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 22: South Asia Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 23: South Asia Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 24: South Asia Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 25: Oceania Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 26: Oceania Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 27: Oceania Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 28: Oceania Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031
Table 29: MEA Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031
Table 30: MEA Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031
Table 31: MEA Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031
Table 32: MEA Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031